期刊文献+

重症监护病房中革兰阴性菌耐药机制及抗菌药物应用对策 被引量:3

Drug-resistance mechanisms of Gram-negative bacilli in intensive care unit and the strategies for application of antimicrobial drugs
下载PDF
导出
摘要 革兰阴性菌(G-菌)主要耐药机制有以下三方面:使药物失活、阻止药物到达作用靶、药物作用靶位改变。G-菌感染用药对策包括:尽量减少抗生素不适当应用,尽早应用有针对性的敏感抗生素。本文通过分析重症监护病房中G-菌耐药机制及抗菌药物应用对策,为临床合理用药提供参考。 Drug resistance of Gram-negative bacilli has been developed through the following three basic mechanisms: drug inactivation by producing enzymes, prevention of drug access to the target, and alternation of the drug target. Application strategies of medicine include minimizing inappropriate use of broad-spectrum antibiotics and optimal use of appropriate antibiotics as early as possible. Drug-resistance mechanisms of Gram-negative bacteria and the application of antibiotics in intensive care unit are introduced in order to give reference for clinical rational application of antibiotics.
作者 黄静霞 黄怡
出处 《药学服务与研究》 CAS CSCD 2003年第4期256-258,共3页 Pharmaceutical Care and Research
关键词 耐药性 细菌 抗菌药 重症监护室 drug resistance bacteria antibiotic intense care unit
  • 相关文献

参考文献9

二级参考文献29

  • 1刘明德.三所医院内不动杆菌的分离及理化因子敏感性研究[J].医院内感染与管理杂志,1990,5(1):22-22.
  • 2Steward CD,Rasheed JK,Hubert SK,et al. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the NCCLS Extended spectrum β-lactamases detection methods. J Clinic Microbiol, 2001,39(8): 2864~2872.
  • 3Bou G,Oliver A,Ojeda M,et al. Molecular characterization of FOX-4, a new AmpC-type plasmid mediated β-lactamase from an escherichia coli strain isolated in spain. Antimicrob Agents Chemother,2000,44(9) :2549~2553.
  • 4Essack SY,Hall MC,Pillay DG,et al. Complexity and diversity of Klebsiella pneumoniae strains with Extended spectrum β-lactamases isolated in 1994 and 1996 at a teaching hospital in Durban,South Africa. Antimicrob Agents Chemother, 2001,45 (1): 88~95.
  • 5Bou G, Jesus MB. Cloning , nucleotide sequencing, and analysis of the gene encoding an AmpC lactamase in acinetobacter baumannii.Antimicrob Agents Chemother,2000,44(2):428~432.
  • 6Masuda N, Sakagawa E, Ohya S,et al. Hypersusceptibility of the pseudomonas aeruginosa to β-lactamase due to reduced expression of the AmpC lactamase. Antimicrob Agents Chemother, 2001,45 (4):1284~1286.
  • 7吕媛,中国临床药理学杂志,1999年,15卷,161页
  • 8Tai P C,Anal Biochem,1985年,144卷,199页
  • 9SURI A,MAHAPATRA A K,KAPIL A,et al.Acinetobacter infection in neurosurgical intensive care patients[J].Natl Med J India,2000,13(6):296-300.
  • 10D′AGATA E M,THAYER V,SCHAFFNER W,et al.An outbreak of Acinetobacter baumannii:the importance of cross transmission[J].Infect Control Hosp Epidemiol,2000,21(9):588-591.

共引文献158

同被引文献20

  • 1张翊,卢建平.鲍氏不动杆菌感染及耐药性变化的趋势[J].中华医院感染学杂志,2004,14(3):341-343. 被引量:91
  • 2黄勋,徐秀华,黄昕,吴安华,文细毛,李洁.重症监护病房铜绿假单胞菌、鲍曼不动杆菌的耐药性研究[J].医学临床研究,2004,21(12):1361-1363. 被引量:5
  • 3李苏利,李杨,华川.多重耐药鲍氏不动杆菌耐药现状与临床对策[J].中华医院感染学杂志,2005,15(12):1438-1440. 被引量:102
  • 4朱旭慧,孙自镛,简翠,李丽,张蓓,申正义.不动杆菌属的耐药性分析[J].中国抗感染化疗杂志,2005,5(6):342-345. 被引量:37
  • 5骆俊,吴卫红,徐晓刚,林东昉,朱德妹,汪复.耐亚胺培南革兰阴性杆菌产碳青霉烯酶研究[J].中华检验医学杂志,2007,30(5):510-514. 被引量:17
  • 6Baumgart AM,Molinari MA,Silveira AC.Prevalence of carbapenemresistant Pseudomonas aeruginosa and Acinetobacter baumannii inhigh complexity hospital[J].Braz J Infect Dis,2010,14(5):433-436.
  • 7Via J,Marcos A,Marco F,et a1.In vitro antimicrobial produefion ofbeta-lacramases.aminoglycoside modifying enzylnc8,and chlora-mphenicol acetyltran sferase and suscepfibilityof clinical isolatesof acinetobacter baumanni[J].Antimicrob Asent Chemother,1993,37(1):138-141.
  • 8WHO Collaborating Centre for Drug Statistics Methodology.Complete ATC index. http://www.whocc.no/atcddd/ . 2009
  • 9Mohr JF,Jones A,Ostrosky-Zeichnera L,et al.As-sociations between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in a private,university–affiliated teaching hospital:an8-year-experience:1995-2002. Interna-tional Journal of Antimicrobial Agents . 2004
  • 10Via J,Marcos A,Marco F,et al.In vitro antimicrobial production of beta-lactamases, aminoglycoside modifying enzymes, and chloramphenicol acetyltransferase and susceptibility of clinical isolates of acinetobacter baumanni. Antimicrobial Agents and Chemotherapy . 1993

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部